Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Shares Issued (2020 - 2025)

Caribou Biosciences (CRBU) has disclosed Shares Issued for 5 consecutive years, with $745000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued fell 94.78% to $745000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $745000.0, a 95.1% decrease, with the full-year FY2025 number at $745000.0, down 95.1% from a year prior.
  • Shares Issued was $745000.0 for Q4 2025 at Caribou Biosciences, down from $14.3 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $319.9 million in Q3 2021 to a low of -$1.5 million in Q4 2023.
  • A 4-year average of $33.6 million and a median of $593000.0 in 2023 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: soared 230036.69% in 2021, then tumbled 99.15% in 2024.
  • Caribou Biosciences' Shares Issued stood at $319.9 million in 2021, then crashed by 100.47% to -$1.5 million in 2023, then soared by 1046.88% to $14.3 million in 2024, then crashed by 94.78% to $745000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Shares Issued are $745000.0 (Q4 2025), $14.3 million (Q4 2024), and $244000.0 (Q3 2024).